Frequency, clinical features and differential response to therapy of concurrent ALK/EGFR alterations in Chinese lung cancer patients

Frequency, clinical features and differential response to therapy of concurrent ALK/EGFR alterations in Chinese lung cancer patients

Jixian Liu,1,* Zhimin Mu,1,* Li Liu,2 Kang Li,2 Richeng Jiang,3 Peng Chen,3 Qiang Zhou,4 Meiling Jin,5 Yuxiang Ma,6 Yuancai Xie,1 Jianxing Xiang,7 Bing Li,7 Yafeng Ma,7 Xinru Mao,7 Lu Zhang,7 Tengfei Zhang,7 Da Wu11Department of Thoracic Surgery, Peking University Shenzhen Hospital, Shenzhen 518035,...

Full description

Bibliographic Details
Main Authors: Liu J, Mu Z, Liu L, Li K, Jiang R, Chen P, Zhou Q, Jin M, Ma Y, Xie Y, Xiang J, Li B, Mao X, Zhang L, Zhang T, Wu D
Format: Article
Language:English
Published: Dove Medical Press 2019-05-01
Series:Drug Design, Development and Therapy
Subjects:
EGFR alteration
ALK rearrangement
non-small cell lung cancer
EML4-ALK
tyrosine kinase inhibitor
Online Access:https://www.dovepress.com/frequency-clinical-features-and-differential-response-to-therapy-of-co-peer-reviewed-article-DDDT

Internet

https://www.dovepress.com/frequency-clinical-features-and-differential-response-to-therapy-of-co-peer-reviewed-article-DDDT

Similar Items